Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Ferric Derisomaltose, EPO, and Tranexamic Acid in Bone Tumor Surgery
NCT07314424Phase 4Not yet recruiting
- Start
- Jan 2026
- Primary completion
- Oct 2027
- Modality
- Inorganic Nanoparticles, Small Molecules
01
Overview
A Phase 4 trial of ferric derisomaltose in anemia, iron deficiency anemia (IDA). Planned start Jan 2026; status: not yet recruiting.
02
Drugs
ferric derisomaltose
03
Conditions
anemiairon deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT07314424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07314424.